Ton Lisman mostly deals with Internal medicine, Surgery, Liver transplantation, Hemostasis and Liver disease. His Internal medicine research incorporates elements of Gastroenterology, Endocrinology and Immunology. His Immunology research integrates issues from Antithrombin and Coagulation.
His work on Thrombosis, Coagulopathy and Hepatectomy is typically connected to Central venous pressure as part of general Surgery study, connecting several disciplines of science. The concepts of his Hemostasis study are interwoven with issues in Blood coagulation test, Chronic liver disease, Cirrhosis, Thrombomodulin and Intensive care medicine. While the research belongs to areas of Liver disease, Ton Lisman spends his time largely on the problem of Von Willebrand factor, intersecting his research to questions surrounding Disseminated intravascular coagulation.
His main research concerns Internal medicine, Gastroenterology, Liver transplantation, Cirrhosis and Surgery. His studies examine the connections between Internal medicine and genetics, as well as such issues in Endocrinology, with regards to Myocardial infarction. His study in Gastroenterology is interdisciplinary in nature, drawing from both Anticoagulant and Sepsis.
As a part of the same scientific study, Ton Lisman usually deals with the Liver transplantation, concentrating on Pathology and frequently concerns with Bile duct. His study looks at the intersection of Cirrhosis and topics like Platelet with Biochemistry and Liver regeneration. His Thrombosis research incorporates themes from Odds ratio and Risk factor.
His primary scientific interests are in Internal medicine, Gastroenterology, Liver disease, Cirrhosis and Liver transplantation. His Internal medicine and Coagulation, Thrombosis, Von Willebrand factor, Portal vein thrombosis and Heparin investigations all form part of his Internal medicine research activities. His Coagulation research is multidisciplinary, incorporating perspectives in Platelet and Antithrombin.
The study incorporates disciplines such as Low molecular weight heparin, Fibrinolysis and Thrombin in addition to Gastroenterology. The various areas that Ton Lisman examines in his Liver disease study include Thrombelastography, Fresh frozen plasma, Review article and Hemostasis, Hemostatics. As a member of one scientific family, Ton Lisman mostly works in the field of Cirrhosis, focusing on Thrombomodulin and, on occasion, Healthy volunteers, Whole blood, Coagulation testing, Hematocrit and Platelet-poor plasma.
His primary areas of study are Internal medicine, Gastroenterology, Liver disease, Cirrhosis and Coagulation. His research in Internal medicine is mostly focused on Thrombosis. His Gastroenterology study incorporates themes from Hemostasis, Fibrinolysis, Thrombin and MEDLINE.
His Liver disease study combines topics in areas such as Chronic liver disease, Fresh frozen plasma and Surgery, Sepsis. Ton Lisman interconnects Thrombelastography, Thrombomodulin, Thrombin generation and Hemostatics in the investigation of issues within Cirrhosis. Ton Lisman has included themes like Antithrombin, Prothrombin time and Von Willebrand factor in his Coagulation study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences
Ton Lisman;Robert J. Porte.
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity.
Ton Lisman;Ton Lisman;Tamara N. Bongers;Jelle Adelmeijer;Harry L.A. Janssen.
Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management
Stephen H. Caldwell;Maureane Hoffman;Ton Lisman;B. Gail Macik.
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
Mirjam E. Meltzer;Mirjam E. Meltzer;Ton Lisman;Ton Lisman;Philip G. de Groot;Joost C.M. Meijers.
Hemostasis and thrombosis in patients with liver disease: The ups and downs
Ton Lisman;Stephen H. Caldwell;Andrew K. Burroughs;Patrick G. Northup.
Journal of Hepatology (2010)
Thrombin-Activatable Fibrinolysis Inhibitor Deficiency in Cirrhosis Is Not Associated With Increased Plasma Fibrinolysis
Ton Lisman;Frank W.G. Leebeek;Laurent O. Mosnier;Bonno N. Bouma.
Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1
Robert Jan Lebbink;Talitha Eshuis-de Ruiter;Jelle Adelmeijer;Arjan B. Brenkman.
Journal of Experimental Medicine (2006)
Reduced Plasma Fibrinolytic Potential Is a Risk Factor for Venous Thrombosis.
Ton Lisman;Philip G. de Groot;Joost C.M. Meijers;Frits R. Rosendaal.
Haemostatic abnormalities in patients with liver disease
Ton Lisman;Frank W.G. Leebeek;Philip G. de Groot.
Journal of Hepatology (2002)
Lupus anticoagulants and the risk of a first episode of deep venous thrombosis
P. G De Groot;B. Lutters;R. H. W. M. Derksen;T. Lisman.
Journal of Thrombosis and Haemostasis (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: